Skin Manifestations D012877

Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Skin Manifestations

Description

Dermatologic disorders attendant upon non-dermatologic disease or injury.   MeSH

Hierarchy View

Subtype Terms (12)

Cafe-au-Lait Spots
 

Cellulite
7 drugs (4 approved, 3 experimental)

Ecchymosis
8 drugs (5 approved, 3 experimental)

Erythema
38 drugs (24 approved, 14 experimental)

Flushing
22 drugs (12 approved, 10 experimental)

Jaundice
6 drugs (4 approved, 2 experimental)

Livedo Reticularis
 

Necrolytic Migratory Erythema
1 approved drug

Pallor
 

Pruritus
118 drugs (66 approved, 52 experimental)

Purpura
52 drugs (35 approved, 17 experimental)

Striae Distensae
3 drugs (1 approved, 2 experimental)


Approved Indicated Drugs (1)

Phase 4 Indicated Drugs (2)

Phase 1 Indicated Drugs (1)


Organization Involved with Phase 4 Indications (1)

Organization Involved with Phase 2 Indications (1)

Organization Involved with Other Experimental Indications (4)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.